| Laura L Davis, APNP | |
|
411 Lincoln St, Neenah, WI 54956-2753 | |
| (920) 727-4220 | |
| Not Available |
| Full Name | Laura L Davis |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 11 Years |
| Location | 411 Lincoln St, Neenah, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205268398 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 5358 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension At Home | Neenah, WI | Home health agency |
| Ascension Ne Wisconsin - St Elizabeth Campus | Appleton, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ascension Medical Group-fox Valley Wisconsin Inc | 0244142420 | 258 |
News Archive
The Toronto General Hospital today becomes the first healthcare institution in the world to unveil a novel technology-based platform aimed at shortening the time required to translate medical research into clinical practice. This will enable faster diagnoses and more rapid treatment for patients with heart disease and other conditions that are detected using advanced medical imaging devices.
Sharps Compliance Corp., a leading full-service provider of cost-effective management solutions for medical waste and unused dispensed medications generated outside the hospital and large healthcare facility setting, announced today that it has entered into a new $5.0 million, two-year Credit Agreement with Wells Fargo Bank, National Association.
In a recent study published in the journal Pathogens, researchers carried out a molecular docking study for 17 structural analogs prepared from natural maslinic and oleanolic acids and screened them against SARS-CoV-2 main protease. They also experimentally validated the data by determining the half-maximal cytotoxic and inhibitory concentrations of each of the 17 compounds. The researchers investigated whether the compound with antiviral activity affected viral adsorption, replication, or viricidal effect using a plaque infectivity reduction assay.
Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing new treatments for prostate cancer, today announced that additional data from a Phase 1 safety and proof-of-concept study evaluating lead candidate, galeterone, in patients with castration-resistant prostate cancer (CRPC) will be highlighted in a poster presentation titled, "Phase I clinical trial of galeterone, a multifunctional anti-androgen and CYP17 inhibitor in castration resistant prostate cancer," abstract number 4665, on Sunday, June 3, 2012, 8:00 a.m. to 12:00 p.m. at the 2012 Annual Meeting of the American Society of Clinical Oncology.
› Verified 7 days ago
| Entity Name | Ascension Medical Group-fox Valley Wisconsin Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730126392 PECOS PAC ID: 0244142420 Enrollment ID: O20031105000351 |
News Archive
The Toronto General Hospital today becomes the first healthcare institution in the world to unveil a novel technology-based platform aimed at shortening the time required to translate medical research into clinical practice. This will enable faster diagnoses and more rapid treatment for patients with heart disease and other conditions that are detected using advanced medical imaging devices.
Sharps Compliance Corp., a leading full-service provider of cost-effective management solutions for medical waste and unused dispensed medications generated outside the hospital and large healthcare facility setting, announced today that it has entered into a new $5.0 million, two-year Credit Agreement with Wells Fargo Bank, National Association.
In a recent study published in the journal Pathogens, researchers carried out a molecular docking study for 17 structural analogs prepared from natural maslinic and oleanolic acids and screened them against SARS-CoV-2 main protease. They also experimentally validated the data by determining the half-maximal cytotoxic and inhibitory concentrations of each of the 17 compounds. The researchers investigated whether the compound with antiviral activity affected viral adsorption, replication, or viricidal effect using a plaque infectivity reduction assay.
Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing new treatments for prostate cancer, today announced that additional data from a Phase 1 safety and proof-of-concept study evaluating lead candidate, galeterone, in patients with castration-resistant prostate cancer (CRPC) will be highlighted in a poster presentation titled, "Phase I clinical trial of galeterone, a multifunctional anti-androgen and CYP17 inhibitor in castration resistant prostate cancer," abstract number 4665, on Sunday, June 3, 2012, 8:00 a.m. to 12:00 p.m. at the 2012 Annual Meeting of the American Society of Clinical Oncology.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Laura L Davis, APNP 411 Lincoln St, Neenah, WI 54956-2753 Ph: (920) 727-4220 | Laura L Davis, APNP 411 Lincoln St, Neenah, WI 54956-2753 Ph: (920) 727-4220 |
News Archive
The Toronto General Hospital today becomes the first healthcare institution in the world to unveil a novel technology-based platform aimed at shortening the time required to translate medical research into clinical practice. This will enable faster diagnoses and more rapid treatment for patients with heart disease and other conditions that are detected using advanced medical imaging devices.
Sharps Compliance Corp., a leading full-service provider of cost-effective management solutions for medical waste and unused dispensed medications generated outside the hospital and large healthcare facility setting, announced today that it has entered into a new $5.0 million, two-year Credit Agreement with Wells Fargo Bank, National Association.
In a recent study published in the journal Pathogens, researchers carried out a molecular docking study for 17 structural analogs prepared from natural maslinic and oleanolic acids and screened them against SARS-CoV-2 main protease. They also experimentally validated the data by determining the half-maximal cytotoxic and inhibitory concentrations of each of the 17 compounds. The researchers investigated whether the compound with antiviral activity affected viral adsorption, replication, or viricidal effect using a plaque infectivity reduction assay.
Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing new treatments for prostate cancer, today announced that additional data from a Phase 1 safety and proof-of-concept study evaluating lead candidate, galeterone, in patients with castration-resistant prostate cancer (CRPC) will be highlighted in a poster presentation titled, "Phase I clinical trial of galeterone, a multifunctional anti-androgen and CYP17 inhibitor in castration resistant prostate cancer," abstract number 4665, on Sunday, June 3, 2012, 8:00 a.m. to 12:00 p.m. at the 2012 Annual Meeting of the American Society of Clinical Oncology.
› Verified 7 days ago
Mrs. Amanda Kay Douma, APNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 333 N Green Bay Rd Ste B, Neenah, WI 54956 Phone: 920-454-7130 | |
Lori A. Franck, APNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 100 Theda Clark Medical Plz Ste 400, Neenah, WI 54956 Phone: 920-725-4527 | |
Mrs. Bonnie B Hoersch, APNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 130 2nd St, Neenah, WI 54956 Phone: 920-729-2738 Fax: 920-729-3023 | |
Pamela Macwilliams, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 130 2nd St Ste 197, Neenah, WI 54956 Phone: 920-729-2030 | |
Ellen Beltz, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 130 2nd St, Neenah, WI 54956 Phone: 920-729-2738 | |
Marie K Dziewit, APNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 100 Theda Clark Medical Plz Ste 400, Neenah, WI 54956 Phone: 920-725-4527 Fax: 920-729-2378 | |
Brittany R Burg, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 130 2nd St, Neenah, WI 54956 Phone: 920-729-2030 Fax: 920-729-9384 |